Danbury Pharmacal

Danbury Pharmacal was a prominent American generic pharmaceutical company based in Danbury, Connecticut. Founded in 1966, the company specialized in the development and manufacture of a wide range of generic prescription drugs, primarily focusing on small molecule oral solids. It became a significant player in the U.S. generic market, providing affordable alternatives for cardiovascular, central nervous system, and analgesic medications. Following its involvement in the industry-wide generic drug scandal of the late 1980s, the company was acquired by Schein Pharmaceutical in 1990. Its legacy operations eventually became part of Watson Pharmaceuticals and subsequently Teva Pharmaceutical Industries through further industry consolidation.